ULTRAVATE
Google image searchProduct monograph
Active ingredient
halobetasol propionate, 0.05 %/W/W
DIN: 01962728
Dosage form(s): OINTMENT
Route(s) of administration: TOPICAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 15-OCT-2019
ATC:
- D07 — CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
- D07A — CORTICOSTEROIDS, PLAIN (ATC, ATC/DDD)
- D07AC — Corticosteroids, potent (group III) (ATC, ATC/DDD)
- D07AC21 — ULOBETASOL (ATC/DDD)
Reference brand drug: Ultravate
Pharmaceutical standard: MFR
